imipramine has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laidlaw, KM | 1 |
| Berhan, S | 1 |
| Liu, S | 1 |
| Silvestri, G | 1 |
| Holyoake, TL | 1 |
| Frank, DA | 1 |
| Aggarwal, B | 1 |
| Bonner, MY | 1 |
| Perrotti, D | 1 |
| Jørgensen, HG | 1 |
| Arbiser, JL | 1 |
1 other study available for imipramine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Drug Resistance, Neo | 2016 |